Picture of Viridian Therapeutics logo

VRDN Viridian Therapeutics Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Viridian Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments26.8128197425477
Net Total Accounts Receivable
Net Total Receivables0.1080.4510.1020.102
Prepaid Expenses
Total Current Assets29.7130200431486
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.5230.7872.062.943.34
Other Long Term Assets
Total Assets30.3131204435490
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities10.210.713.633.326.6
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities14.511.2164048.4
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity15.8120188395442
Total Liabilities & Shareholders' Equity30.3131204435490
Total Common Shares Outstanding
Total Preferred Shares Outstanding